TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

OSLER DIAGNOSTICS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

OSLER DIAGNOSTICS

ST13

US500000088923481

Classe

1, 5, 9, 10, 41, 42, 44

Pedido

88923481

Registro

6982744

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

52

Atualização mais recente

08/09/2023

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 10, 41, 42, 44

Data de depósito

19/05/2020

Data de registro

21/02/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

21/02/2023

Última transação

08/09/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Código do desenho

4

Tipo de titular

99

Localização do titular

Oxford, GB

Examinador

WERT, KARL

Unidade examinadora

N20

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Osler Diagnostics Limited

Representantes

Eric Lamb Frost Brown Todd LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 10Classe 41Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Assays and reagents for scientific or medical research purposes

Classe 5

Pharmaceuticals for treating viruses, infections, infectious diseases, and skin disorders; medical preparations for treating viruses, infections, infectious diseases, and skin disorders; chemical preparations and reagents for medical purposes for treating viruses, infections, infectious diseases, and skin disorders; diagnostic preparations, substances, agents, reagents, assays and materials for medical purposes; diagnostic testing preparations, substances, agents, reagents, assays and materials for medical purposes, namely, for testing blood and body fluids

Classe 9

Scientific apparatus and instruments, namely, hand-held devices in the nature of a research laboratory analyzer for withdrawing and testing blood for research and scientific purposes and parts and fittings therefor; scientific research and laboratory apparatus and instruments, namely, laboratory centrifuges; material testing apparatus and instruments, namely, electronic apparatus being a research laboratory analyzer for identifying and testing pathogens and biomarkers in blood for research, and scientific purposes; apparatus for transmission of communication; monitoring, measuring, signaling and control apparatus and instruments in the nature of research laboratory analyzers for testing blood against a panel of biomarkers for research, and scientific purposes; audiovisual receivers; computer apparatus and instruments, namely, computer hardware and computer peripheral apparatus; recorded computer software for analyzing data obtained from blood samples; downloadable computer software for analyzing data obtained from blood samples; downloadable application software for analyzing data obtained from blood samples; computer hardware for data capture, collection, recording, processing, transmission, reproduction, storage and communications; electrical parts being electronic components for computers; and replacement parts therefor

Classe 10

Medical apparatus and instruments for use in obtaining blood samples; medical apparatus and instruments for diagnostic use in analyzing body fluids; medical apparatus and instruments for identifying pathogens and biomarkers from blood samples; diagnostic testing apparatus and instruments for the measurement of clinical biomarkers; and replacement parts therefor

Classe 41

Research in the field of education; consultancy, advisory and information services regarding the aforementioned services in the field of education

Classe 42

Product research and development services; medical testing research and development services; scientific medical testing research and development services; pharmaceutical research and development services; new product design services; research, design and development of medical apparatus and instrument products; research, design and development of medical diagnostic apparatus and instruments products; research, design and development of diagnostic test products for the measurement of clinical biomarkers; computer software research, design and development services; consultancy, advisory and information services regarding the aforementioned services

Classe 44

Medical services; medical testing for diagnostic purposes; medical testing, medical screening and medical analysis services relating to the diagnosis of disease; medical testing, medical screening and medical analysis services relating to the treatment of disease; consultancy, advisory and information services regarding the aforementioned services

Publicações

Histórico de despachos e eventos da marca no USPTO.

52 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/09/2023

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

08/09/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/09/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/09/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

28/02/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

28/02/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

28/02/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

28/02/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

28/02/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

21/02/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

21/02/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/12/2022

PUBO

PUBLISHED FOR OPPOSITION

06/12/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

16/11/2022

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

25/10/2022

OTHE

CASE RETURNED TO EXAMINATION

07/10/2022

IUCN

NOTICE OF ALLOWANCE CANCELLED

07/10/2022

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

07/10/2022

APET

ASSIGNED TO PETITION STAFF

05/10/2022

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

09/09/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

14/07/2022

EX2G

SOU EXTENSION 2 GRANTED

12/07/2022

EXT2

SOU EXTENSION 2 FILED

12/07/2022

EEXT

SOU TEAS EXTENSION RECEIVED

12/07/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

13/01/2022

EX1G

SOU EXTENSION 1 GRANTED

11/01/2022

EXT1

SOU EXTENSION 1 FILED

11/01/2022

EEXT

SOU TEAS EXTENSION RECEIVED

11/01/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

20/07/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

25/05/2021

PUBO

PUBLISHED FOR OPPOSITION

25/05/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/05/2021

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

13/04/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

30/03/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

30/03/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

30/03/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

30/03/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

30/03/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

26/03/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

26/03/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

26/03/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

26/03/2021

DOCK

ASSIGNED TO EXAMINER

01/03/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

26/02/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

25/02/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

25/02/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

25/08/2020

GNRT

NON-FINAL ACTION E-MAILED

25/08/2020

CNRT

NON-FINAL ACTION WRITTEN

25/08/2020

DOCK

ASSIGNED TO EXAMINER

18/08/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/06/2020

NWAP

NEW APPLICATION ENTERED

22/05/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace OSLER DIAGNOSTICS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.